Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quart... (uding statements relating to Lexicon's c...)

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results

Date:4/28/2009

uding statements relating to Lexicon's clinical development of LX1031, LX1032, LX2931, LX4211, and LX7101 and the potential therapeutic and commercial potential of LX1031, LX1032, LX2931, LX4211, and LX7101. This press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX1031, LX1032, LX2931, LX4211, and LX7101 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2008, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.

Lexicon Pharmaceuticals, Inc.
Selected Financial Data

'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved
0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)

Post Your Comments:

(Date:11/27/2009)...INGTON,Minn,Nov.27/PRNewswire/--ACUOTECHNOLOGIES,d...oftware,datamigrationtoolsandservices,ispleasedtoa...hasapprovedapatentapplicationforan"AssetCommunicat...spleasedtoaddtheU.S.patenttoitsportfolioofintellec...broadlyprotectsAcuo,stechnologyanduseofassetmetain...

(Date:11/25/2009)...APARK,Calif.,Nov.25/PRNewswire/--PraxisElectronicM...anAcademyofFamilyPhysicians,(AAFP)FamilyPracticeMa...vingmedicalquality,healthmaintenance,anddiseaseman...raxisalsoranked#1amongdoctorsindicatingtheirEMRhad...axisalsorankednumberoneinthecountryinprovidingexce...

(Date:11/25/2009)...RD,Mass.,Nov.25/PRNewswire-FirstCall/--Hologic,Inc...loper,manufacturerandsupplierofpremiumdiagnostics,...oservingthehealthcareneedsofwomen,isusingtheannual...)atMcCormickPlaceinChicago,November29throughDecemb...odalitydiagnosticmammographyworkstationsoftware. ,...

Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2 New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 2 New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity 3 Obama Declares Swine Flu a National Emergency 60028 1 Obama Declares Swine Flu a National Emergency 60028 2 Obama Declares Swine Flu a National Emergency 60028 3 Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 14588 1 Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 14588 2 Jellyfish Protein Extends Neuroprotective Tentacles at Neuroscience Conference 14588 3 Sinus Dynamics Announced Treatment for MRSA with Nasal Nebulizer and Vancomycin 14586 1 Sinus Dynamics Announced Treatment for MRSA with Nasal Nebulizer and Vancomycin 14586 2

[0] Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network [0] Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey [0] New Hologic SecurView(R) DX Diagnostic Workstation Software Streamlines Workflow, Improves Radiologist Productivity

...tics,Inc. (OTC Bulletin Board: SPDU), today announ...P, Nile,s selective NPR-B agonist being developed ... this study will be included,in the Company,s pres...ancisco, CA. "The development of a peptide that h...ittle effect on blood pressure, is a potentially i...

...limination Act, NEW YORK, Oct. 10 In the spirit ... justice ministry, Black clergy are stepping,forwa...g for theologically,sound HIV/AIDS public policy. ...ion on AIDS (NBLCA), we are determined to live up ...ight of the world." With faithfulness to,this call...

Other Medicine Technology:Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure 2 Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure 3 Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure 4 Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 2 Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 3

Nile Therapeutics Announces Positive Phase 1a Results of CD-NP, a Selective NPR-B Agonist in Clinical Development for the Treatment of Heart Failure Statement From The National Conclave on HIV/AIDS Policy for Black Clergy

(Date:11/25/2009)... Nov. 25 The Bartle Hall Conventio...est medical clinic on Dec. 9-10, when Kansas City ...cs for uninsured people. ,, "This free clinic e...because it will extend over two days instead of ju...eekend," Sheri Wood, executive director of the Kan...

(Date:11/25/2009)...25/PRNewswire/-SentinelleMedicalInc.,aleadingmanuf...wareandCalgaryScientificInc.,aleadingproviderofsof...nofAegis(TM)Breast4DAdvancedVisualizationsoftware....footprintWebclientbasedmedicalimagingofferinginthe...sforzero-footprintaccess-requiringnosoftwaredownlo...

(Date:11/25/2009)..., Nov. 25 Thanksgiving meals will ...ors in the greater Long Beach area thanks to Faith...perated by Independence at Home (IAH), a division ...organizations have gathered hundreds of volunteers...need in Long Beach, Lakewood, Signal Hill, South B...

(Date:11/25/2009).... 25 The Black AIDS Ins...o determine executive leadership for 2010. ,, T... leaders with specialties in public policy, law, f... business entrepreneurship. The Board also comes f... both heterosexual and gay Black men and women, so...

(Date:11/25/2009)...ndorsements, Business, and Press Join Effort to Ed...USNewswire/ -- Once again, the National Bipolar Fo...roclamation endorsing their "Safe ,til Stable" pro...entive health care measure for bipolar disorder. T...roclamation of endorsement via Federal Express Pri...

Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2 Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2 Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3 Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2 Health News:Black AIDS Institute Announces 2010 Board Election Results 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3 Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 4

[1] Kansas City Prepares for Largest Free Health Clinic [1] Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology [0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors [0] Black AIDS Institute Announces 2010 Board Election Results [0] First Time-Door is Open for Family Discussion of Bipolar Disorder

...NSWICK, N.J., Dec. 11 Johnson & Johnson (NYSE... Director of the Antitrust Authority has approved ...rix Biopharmaceuticals, Inc. (Nasdaq: OMRI ), un...008. It commenced, through a new wholly-owned subs...

...OLIS, Dec. 11 Bioenergy Life Science -- The Ribos...to Solutions, LLC, to market,Bioenergy D-Ribose(TM...rring,monosaccharide the body uses to stimulate th...d,expanding D-Ribose into the marketplace," said K...

...OR, Mich., Dec. 11 Three more Michigan start-up,c...through the Michigan,Pre-Seed Capital Fund: Arbor ... 28 Michigan companies have received a combined ...gan Pre-Seed Capital Fund has had consistent deal ...

...ROCK, Ark., Dec. 11 Travel Nurse across America h...for healthcare staffing,services from The Joint Co...ational supplemental healthcare staffing,firm, rec...petency of their traveling nurses and surgical tec...

...AS, Dec. 11 American Pacific Corporation,(Nasdaq:... fiscal 2008 fourth,quarter and year ended Septemb...as a supplement to financial results based on,GAAP...FINANCIAL HIGHLIGHTS , Quarter Ended Septemb...

...ANTONIO - Scientists in the clinic and the laborat...ity rates down with breakthrough drugs. With tamox...t of Herceptin still being felt, researchers are s...CR San Antonio Breast Cancer Symposium. , , Zo...

Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix Bioenergy Life Science Retains Xsto Solutions to Market D-Ribose Michigan Pre-Seed Capital Fund Invests in Three More Michigan Start-Ups Travel Nurse Across America Awarded Certification From The Joint Commission American Pacific Reports Fiscal 2008 Results; Net Income Increases 80%Cancer drugs in the pipeline

...ns most advanced multi-functional microplate detec...performance without compromising flexibility. ,T... the Ultra instrument platform. New features are a...of the existing instrument along with possible upg...

...first monochromator-based microplate reader combin...y for absorbance and fluorescence application need...s selection of wavelengths without the use of filt...ull down menu. , Absorbance, fluorescence intensit...

ViewLux ultraHTS Microplate Imager

Manual VICTOR2 with fluorescence and luminescence technologies

Medicine Products:

ULTRA Evolution Multi-Detection Microplate Reader Safire Multi-Detection Monochrometer Microplate Reader ViewLux ultraHTS Microplate Imager Manual VICTOR2 with fluorescence and luminescence technologies

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quart...(uding statements relating to Lexicon's c...),Health